Misonix hits back at Chinese distributor over FCPA contract dispute
Misonix, a US medical device manufacturer, has defended its decision to terminate the contract of a Chinese distributor after discovering possible foreign bribery violations.
To read more
Subscribe to Global Investigations Review
Subscribe and start reading now
Global Investigations Review (GIR) is the hub for global coverage of corporate investigations and their aftermath. Keep up to date with significant developments in the corporate investigations world.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10